Kainos Laboratories, Inc. operates within the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Kainos Laboratories with three other
pharmaceutical manufacturers in Asia:
BioSino Bio-technology and Science Inc
sales of 295.13 million Chinese Renmimbi [US$47.04 million]
Mizuho Medy Co Ltd
(5.62 billion Japanese Yen [US$52.48 million]
OK Biotech Co Ltd
based in Taiwan
(1.23 billion Taiwanese Dollars [US$42.08 million]
During the year ended March of 2017, sales at
Kainos Laboratories were ¥4.70 billion (US$43.88 million).
decrease of 12.0%
versus 2016, when the company's sales were ¥5.35 billion.
The sales level in 2017 was fairly close to the level five years ago: in 2012, Kainos Laboratories had sales
of ¥4.86 billion.